The Latest Headlines at American Banking and Market News
Moderna (NASDAQ:MRNA) Price Target Raised to $163.00 at Oppenheimer
Moderna (NASDAQ:MRNA – Free Report) had its price objective boosted by Oppenheimer from $142.00 to $163.00 in a report published on Friday, Benzinga reports. The firm currently has an outperform rating on the stock. A number... More of this article »
Cantor Fitzgerald Cuts Fortinet (NASDAQ:FTNT) Price Target to $55.00
Fortinet (NASDAQ:FTNT – Free Report) had its price objective cut by Cantor Fitzgerald from $65.00 to $55.00 in a report released on Friday morning, Benzinga reports. They currently have a neutral rating on the software maker’s... More of this article »
Texas Roadhouse (NASDAQ:TXRH) Price Target Raised to $181.00 at Truist Financial
Texas Roadhouse (NASDAQ:TXRH – Free Report) had its price target increased by Truist Financial from $170.00 to $181.00 in a report issued on Friday, Benzinga reports. Truist Financial currently has a buy rating on the restaurant... More of this article »
Open Text (NASDAQ:OTEX) Price Target Cut to $38.00 by Analysts at Barclays
Open Text (NASDAQ:OTEX – Free Report) (TSE:OTC) had its target price reduced by Barclays from $44.00 to $38.00 in a report released on Friday morning, MarketBeat.com reports. Barclays currently has an equal weight rating on the... More of this article »
Barclays Boosts Paylocity (NASDAQ:PCTY) Price Target to $178.00
Paylocity (NASDAQ:PCTY – Free Report) had its price objective increased by Barclays from $166.00 to $178.00 in a research report report published on Friday morning, Benzinga reports. The firm currently has an equal weight rating... More of this article »
Fortinet (NASDAQ:FTNT) Given New $75.00 Price Target at Barclays
Fortinet (NASDAQ:FTNT – Free Report) had its price target cut by Barclays from $80.00 to $75.00 in a research report sent to investors on Friday, Benzinga reports. They currently have an equal weight rating on the software maker’s... More of this article »
Fortinet (NASDAQ:FTNT) Price Target Lowered to $70.00 at Truist Financial
Fortinet (NASDAQ:FTNT – Free Report) had its price target reduced by Truist Financial from $80.00 to $70.00 in a report published on Friday, Benzinga reports. Truist Financial currently has a buy rating on the software maker’s... More of this article »
Cloudflare (NYSE:NET) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC restated their buy rating on shares of Cloudflare (NYSE:NET – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. Needham & Company LLC currently has a $135.00... More of this article »
Cloudflare (NYSE:NET) Price Target Cut to $110.00
Cloudflare (NYSE:NET – Free Report) had its price objective reduced by TD Cowen from $117.00 to $110.00 in a research report report published on Friday morning, Benzinga reports. They currently have a buy rating on the stock. NET... More of this article »
Van ECK Associates Corp Sells 3,153 Shares of Alliant Energy Co. (NASDAQ:LNT)
Van ECK Associates Corp lessened its stake in Alliant Energy Co. (NASDAQ:LNT – Free Report) by 5.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional... More of this article »
Great Valley Advisor Group Inc. Increases Stake in Johnson & Johnson (NYSE:JNJ)
Great Valley Advisor Group Inc. grew its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 8.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned... More of this article »
New York Life Investment Management LLC Boosts Stake in Manhattan Associates, Inc. (NASDAQ:MANH)
New York Life Investment Management LLC raised its holdings in shares of Manhattan Associates, Inc. (NASDAQ:MANH – Free Report) by 6.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and... More of this article »
Seaview Investment Managers LLC Trims Position in Johnson & Johnson (NYSE:JNJ)
Seaview Investment Managers LLC lessened its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 2.8% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned... More of this article »